个人情况介绍、概览
英国德蒙福特大学莱斯特药学院结晶科学与药物输送系教授。他在中国东北大学获得控制与仪器工程博士学位。目前，他的研究方向集中在结晶科学与工程、口服药物配方设计和输送以及药品制造领域。
主要研究方向
1. 研究方向一：药物共晶筛选和传递
2. 研究方向二：数字化连续制药生产过程设计和优化
3. 研究方向三：新型固体口服剂型的设计和传递
近年来发表代表性论文(限第一作者或通讯作者，SCI须写明影响因子)：
1. Alinda, P., A. Botana, and M. Li, Insight into the Precipitation Inhibition of Polymers within Cocrystal Formulations in Solution Using Experimental and Molecular Modeling Techniques. Crystal Growth & Design, 2025. (IF=3.8)
2. M. A. N. Adegbolagun, K. Wang, T. Yamaguchi, T. Hamaguchi, K. Yoshida, S. Kawata, C.C. Seaton, A, Harano, J Han, Z. Wang & M. Li, Multicomponent Crystal Forms of Albendazole for Bioavailability Improvement. Crystal Growth & Design, 2025. 25(3): p. 540-553. (IF=3.8)
3. Madu, S. J., K. Wang, K., S.K. Chirumamilla, D.B. Turner, P.G. Steel, & M. LI. Assessing Dose-Exposure–Response Relationships of Miltefosine in Adults and Children using Physiologically-Based Pharmacokinetic Modeling Approach. Pharmaceutical Research, 2023, 40(12): 2983-3000. DOI: 10.1007/s11095-023-03610-0. (IF=3.5)
4. Shi, K. & Li, M. Optimisation of Pharmaceutical Cocrystal Dissolution Performance through a Synergistic Precipitation Inhibition. Pharmaceutical Research, 2023, 40(8), 2015-2069. DOI: 10.1007/s11095-023-03532-x. (IF=3.5)
5. Makadia, J., Seaton, C. C. & Li, M. Apigenin Cocrystals: From Computational Prescreening to Physicochemical Property Characterization. Crystal Growth & Design, 2023, 23, 3480-3495. DOI: 10.1021/acs.cgd.3c00030. (IF=3.8)
6. Hall, A.V., Gostick, I.E.F., Yufit, D.S., Marchant, G.Y., Kirubakaran, P., Madu, S.J., Li, M., Steel, P.G., and Steed, J.W., Integral Role of Water in the Solid-State Behavior of the Antileishmanial Drug Miltefosine. Crystal Growth & Design, 2022, 22 (10): 6262-66. DOI: 10.1021/acs.cgd.2c00843. (IF=3.8)
7. Alinda, P., Shi, K., and Li, M., Nucleation of Supersaturated Flufenamic Acid Cocrystal Solutions in the Presence of a Polymer. Crystal Growth & Design, 2022, 22(9), 5215-5228. DOI: 10.1021/acs.cgd.2c00323. (IF=3.8)
8. Makadia, J., Madu, S. J., Arroo, R., Seaton, C. C. Li, M., Artemisinin–acetylenedicarboxylic acid cocrystal: screening, structure determination, and physicochemical property characterisation. CrystEngComm, 2022, 24, p. 1056-1067. DOI: 10.1039/D1CE01400E.(IF=3.756)
9. Kaur, M., Yardley, V., Wang, K., Masania, J., Arroo, R., Turner, D., Li, M., Artemisinin Cocrystals for Bioavailability Enhancement: Part 2. In-vivo Bioavailability and PBPK Modelling, Molecular Pharmaceutics, 2021, 18(12): 4272-4289. DOI: 10.1021/acs.molpharmaceut.1c00385.(IF=4.5)
10. Kaur, M., Yardley, V., Wang, K., Masania, J., Botana, A. Arroo, R., Li, M., Artemisinin Cocrystals for Bioavailability Enhancement: Part 1. Formulation Design and Role of the Polymeric Excipient, Molecular Pharmaceutics, 2021, 18(12): 4256-4271. DOI: 10.1021/acs.molpharmaceut.1c00384. (IF=4.5)